164 related articles for article (PubMed ID: 28919782)
1. Inhibitory effects of a selective Jak2 inhibitor on adrenocorticotropic hormone production and proliferation of corticotroph tumor AtT20 cells.
Asari Y; Kageyama K; Nakada Y; Tasso M; Takayasu S; Niioka K; Ishigame N; Daimon M
Onco Targets Ther; 2017; 10():4329-4338. PubMed ID: 28919782
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitin-specific protease 8 inhibitor suppresses adrenocorticotropic hormone production and corticotroph tumor cell proliferation.
Kageyama K; Asari Y; Sugimoto Y; Niioka K; Daimon M
Endocr J; 2020 Feb; 67(2):177-184. PubMed ID: 31666445
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of trichostatin A on adrenocorticotropic hormone production and proliferation of corticotroph tumor AtT-20 cells.
Nakada Y; Kageyama K; Sugiyama A; Desaki R; Takayasu S; Niioka K; Murasawa S; Ishigame N; Asari Y; Iwasaki Y; Daimon M
Endocr J; 2015; 62(12):1083-90. PubMed ID: 26497760
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of heat shock protein 90 decreases ACTH production and cell proliferation in AtT-20 cells.
Sugiyama A; Kageyama K; Murasawa S; Ishigame N; Niioka K; Daimon M
Pituitary; 2015 Aug; 18(4):542-53. PubMed ID: 25280813
[TBL] [Abstract][Full Text] [Related]
5. Involvement of histone deacetylase 1/2 in adrenocorticotropic hormone synthesis and proliferation of corticotroph tumor AtT-20 cells.
Hagiwara R; Kageyama K; Niioka K; Takayasu S; Tasso M; Daimon M
Peptides; 2021 Feb; 136():170441. PubMed ID: 33181265
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of SOM230 on adrenocorticotropic hormone production and corticotroph tumor cell proliferation in vitro and in vivo.
Murasawa S; Kageyama K; Sugiyama A; Ishigame N; Niioka K; Suda T; Daimon M
Mol Cell Endocrinol; 2014 Aug; 394(1-2):37-46. PubMed ID: 25011056
[TBL] [Abstract][Full Text] [Related]
7. Lapatinib decreases the ACTH production and proliferation of corticotroph tumor cells.
Asari Y; Kageyama K; Sugiyama A; Kogawa H; Niioka K; Daimon M
Endocr J; 2019 Jun; 66(6):515-522. PubMed ID: 30880293
[TBL] [Abstract][Full Text] [Related]
8. Effects of tubastatin A on adrenocorticotropic hormone synthesis and proliferation of AtT-20 corticotroph tumor cells.
Hagiwara R; Kageyama K; Iwasaki Y; Niioka K; Daimon M
Endocr J; 2022 Sep; 69(9):1053-1060. PubMed ID: 35296577
[TBL] [Abstract][Full Text] [Related]
9. Aphidicolin inhibits cell proliferation via the p53-GADD45β pathway in AtT-20 cells.
Kageyama K; Sugiyama A; Murasawa S; Asari Y; Niioka K; Oki Y; Daimon M
Endocr J; 2015; 62(7):645-54. PubMed ID: 25948499
[TBL] [Abstract][Full Text] [Related]
10. Targeting the ERK pathway for the treatment of Cushing's disease.
Zhang D; Bergsneider M; Wang MB; Heaney AP
Oncotarget; 2016 Oct; 7(43):69149-69158. PubMed ID: 27708250
[TBL] [Abstract][Full Text] [Related]
11. Metformin inhibits cell proliferation and ACTH secretion in AtT20 cells via regulating the MAPK pathway.
Sun Y; Cheng J; Nie D; Fang Q; Li C; Zhang Y
Mol Cell Endocrinol; 2024 Mar; 582():112140. PubMed ID: 38147953
[TBL] [Abstract][Full Text] [Related]
12. Effects of RXR Agonists on Cell Proliferation/Apoptosis and ACTH Secretion/Pomc Expression.
Saito-Hakoda A; Uruno A; Yokoyama A; Shimizu K; Parvin R; Kudo M; Saito-Ito T; Sato I; Kogure N; Suzuki D; Shimada H; Yoshikawa T; Fujiwara I; Kagechika H; Iwasaki Y; Kure S; Ito S; Sugawara A
PLoS One; 2015; 10(12):e0141960. PubMed ID: 26714014
[TBL] [Abstract][Full Text] [Related]
13. Cyclin E-Mediated Human Proopiomelanocortin Regulation as a Therapeutic Target for Cushing Disease.
Liu NA; Araki T; Cuevas-Ramos D; Hong J; Ben-Shlomo A; Tone Y; Tone M; Melmed S
J Clin Endocrinol Metab; 2015 Jul; 100(7):2557-64. PubMed ID: 25942479
[TBL] [Abstract][Full Text] [Related]
14. Expression of genes related to corticotropin production and glucocorticoid feedback in corticotroph adenomas of dogs with Cushing's disease.
Teshima T; Hara Y; Takekoshi S; Teramoto A; Osamura RY; Tagawa M
Domest Anim Endocrinol; 2009 Jan; 36(1):3-12. PubMed ID: 18818046
[TBL] [Abstract][Full Text] [Related]
15. The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5.
Hofland LJ; van der Hoek J; Feelders R; van Aken MO; van Koetsveld PM; Waaijers M; Sprij-Mooij D; Bruns C; Weckbecker G; de Herder WW; Beckers A; Lamberts SW
Eur J Endocrinol; 2005 Apr; 152(4):645-54. PubMed ID: 15817922
[TBL] [Abstract][Full Text] [Related]
16. EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas.
Fukuoka H; Cooper O; Ben-Shlomo A; Mamelak A; Ren SG; Bruyette D; Melmed S
J Clin Invest; 2011 Dec; 121(12):4712-21. PubMed ID: 22105169
[TBL] [Abstract][Full Text] [Related]
17. Growth suppression of mouse pituitary corticotroph tumor AtT20 cells by curcumin: a model for treating Cushing's disease.
Bangaru ML; Woodliff J; Raff H; Kansra S
PLoS One; 2010 Apr; 5(4):e9893. PubMed ID: 20405005
[TBL] [Abstract][Full Text] [Related]
18. Cold inducible RNA binding protein upregulation in pituitary corticotroph adenoma induces corticotroph cell proliferation via Erk signaling pathway.
Jian F; Chen Y; Ning G; Fu W; Tang H; Chen X; Zhao Y; Zheng L; Pan S; Wang W; Bian L; Sun Q
Oncotarget; 2016 Feb; 7(8):9175-87. PubMed ID: 26824322
[TBL] [Abstract][Full Text] [Related]
19. AT-101 acts as anti-proliferative and hormone suppressive agent in mouse pituitary corticotroph tumor cells.
Yurekli BS; Karaca B; Kisim A; Bozkurt E; Atmaca H; Cetinkalp S; Ozgen G; Yilmaz C; Uzunoglu S; Uslu R; Saygili F
J Endocrinol Invest; 2018 Feb; 41(2):233-240. PubMed ID: 28730425
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-6 is inhibited by glucocorticoids and stimulates ACTH secretion and POMC expression in human corticotroph pituitary adenomas.
Pereda MP; Lohrer P; Kovalovsky D; Perez Castro C; Goldberg V; Losa M; Chervín A; Berner S; Molina H; Stalla GK; Renner U; Arzt E
Exp Clin Endocrinol Diabetes; 2000; 108(3):202-7. PubMed ID: 10926317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]